Ethinylestradiol/desogestrel explained
Ethinylestradiol/desogestrel (EE/DSG), sold under the brand name Marvelon among others, is a fixed-dose combination of ethinylestradiol (EE), an estrogen, and desogestrel (DSG), a progestin, which is used as a birth control pill to prevent pregnancy in women.[1] [2] It is taken by mouth.
It was approved for medical use in the United Kingdom in 1981, and in the United States in 1992. In 2022, it was the 161st most commonly prescribed medication in the United States, with more than 3million prescriptions.[3] [4]
See also
- List of combined sex-hormonal preparations § Estrogens and progestogens
Notes and References
- Book: Pundir J, Coomarasamy A . Gynaecology: Evidence-Based Algorithms. 21 April 2016. Cambridge University Press. 978-1-316-30110-4. 260–.
- Book: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. World Health Organization. International Agency for Research on Cancer. Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. 2007. World Health Organization. 978-92-832-1291-1. 435, 436, 455, 459.
- Web site: The Top 300 of 2022 . ClinCalc . 30 August 2024 . 30 August 2024 . https://web.archive.org/web/20240830202410/https://clincalc.com/DrugStats/Top300Drugs.aspx . live .
- Web site: Desogestrel; Ethinyl Estradiol Drug Usage Statistics, United States, 2013 - 2022 . ClinCalc . 30 August 2024 .
